{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:20:44Z","timestamp":1789039244893,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10067-021-05880-8","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:11:01Z","timestamp":1630109461000},"page":"159-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Reasons for hospitalization and in-hospital mortality for anti-neutrophil cytoplasmic antibody vasculitides: analysis of the National Inpatient Sample"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2023-8206","authenticated-orcid":false,"given":"Mavi","family":"Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Villafranca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Khamooshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Manadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"issue":"1","key":"5880_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.7861\/clinmedicine","volume":"17","author":"M Yates","year":"2017","unstructured":"Yates M, Watts R (2017) ANCA-associated vasculitis. Clin Med (Lond) 17(1):60\u201364. https:\/\/doi.org\/10.7861\/clinmedicine","journal-title":"Clin Med (Lond)"},{"key":"5880_CR2","unstructured":"Singh JA (2021) Infection versus cardiovascular disease as leading causes of hospitalisations and associated mortality in vasculitis in the U.S.: a national study. ClinExp Rheumatol. 39 Suppl 129(2):56\u201361"},{"issue":"12","key":"5880_CR3","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1093\/rheumatology\/keaa069","volume":"59","author":"P Ungprasert","year":"2020","unstructured":"Ungprasert P, Koster MJ, Cheungpasitporn W, Wijarnpreecha K, Thongprayoon C, Kroner PT (2020) Inpatient epidemiology and economic burden of granulomatosis with polyangiitis: a 10-year study of the national inpatient sample. Rheumatol (Oxford) 59(12):3685\u20133689. https:\/\/doi.org\/10.1093\/rheumatology\/keaa069","journal-title":"Rheumatol (Oxford)"},{"issue":"9","key":"5880_CR4","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1093\/rheumatology\/kez589","volume":"59","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Fu X, Harkness T, Stone JH, Zhang Y, Choi H (2020) All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. Rheumatol (Oxford) 59(9):2308\u20132315. https:\/\/doi.org\/10.1093\/rheumatology\/kez589","journal-title":"Rheumatol (Oxford)"},{"issue":"5","key":"5880_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/RHU.0000000000001045","volume":"26","author":"Y Luo","year":"2020","unstructured":"Luo Y, Jiang C, Arevalo Molina AB, Murray S, Anez GC, Salgado M, Xu J (2020) Thirty-day hospital readmissions for granulomatosis with polyangiitis in the United States: a nationwide analysis. J Clin Rheumatol 26(5):192\u2013196. https:\/\/doi.org\/10.1097\/RHU.0000000000001045","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"5880_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MAJ.0b013e31816805fa","volume":"336","author":"F Holguin","year":"2008","unstructured":"Holguin F, Ramadan B, Gal AA, Roman J (2008) Prognostic factors for hospital mortality and ICU admission in patients with ANCA-related pulmonary vasculitis. Am J Med Sci 336(4):321\u2013326. https:\/\/doi.org\/10.1097\/MAJ.0b013e31816805fa","journal-title":"Am J Med Sci"},{"issue":"6","key":"5880_CR7","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/rheumatology\/keaa699","volume":"60","author":"J Rathmann","year":"2021","unstructured":"Rathmann J, Jayne D, Segelmark M, J\u00f6nsson G, Mohammad AJ (2021) Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study. Rheumatol (Oxford) 60(6):2745\u20132754. https:\/\/doi.org\/10.1093\/rheumatology\/keaa699","journal-title":"Rheumatol (Oxford)"},{"key":"5880_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24348","author":"JA Singh","year":"2020","unstructured":"Singh JA, Cleveland JD (2020) Epidemiology, Time-trends and outcomes of serious infections in patients with vasculitis: a 19-year national study. Arthritis Care Res (Hoboken). https:\/\/doi.org\/10.1002\/acr.24348","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5880_CR9","unstructured":"Golenbiewski J, Eudy A, Clowse M, Allen N. Hospital admissions and mortality in patients with ANCA-associated vasculitis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https:\/\/acrabstracts.org\/abstract\/hospital-admissions-and-mortality-in-patients-with-anca-associated-vasculitis\/. Accessed June 28, 2021."},{"issue":"9","key":"5880_CR10","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3899\/jrheum.131426","volume":"41","author":"QY Lai","year":"2014","unstructured":"Lai QY, Ma TT, Li ZY, Chang DY, Zhao MH, Chen M (2014) Predictors for mortality in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a study of 398 Chinese patients. J Rheumatol 41(9):1849\u20131855. https:\/\/doi.org\/10.3899\/jrheum.131426","journal-title":"J Rheumatol"},{"issue":"6","key":"5880_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5414\/cnp64475","volume":"64","author":"HM Lode","year":"2005","unstructured":"Lode HM, Schmidt-Ioanas M (2005) Vasculitis and infection: effects of immunosuppressive therapy. Clin Nephrol 64(6):475\u2013479. https:\/\/doi.org\/10.5414\/cnp64475","journal-title":"Clin Nephrol"},{"issue":"4","key":"5880_CR12","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1378\/chest.08-3043","volume":"136","author":"JA G\u00f3mez-Puerta","year":"2009","unstructured":"G\u00f3mez-Puerta JA, Hern\u00e1ndez-Rodr\u00edguez J, L\u00f3pez-Soto A, Bosch X (2009) Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease. Chest 136(4):1101\u20131111. https:\/\/doi.org\/10.1378\/chest.08-3043","journal-title":"Chest"},{"issue":"2","key":"5880_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1378\/chest.110.2.357","volume":"110","author":"JC Ter Maaten","year":"1996","unstructured":"Ter Maaten JC, Franssen CF, Gans RO, van Schijndel RJ, Hoorntje SJ (1996) Respiratory failure in ANCA-associated vasculitis. Chest 110(2):357\u2013362. https:\/\/doi.org\/10.1378\/chest.110.2.357","journal-title":"Chest"},{"issue":"1","key":"5880_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.amjmed.2004.02.030","volume":"117","author":"P Seo","year":"2004","unstructured":"Seo P, Stone JH (2004) The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 117(1):39\u201350. https:\/\/doi.org\/10.1016\/j.amjmed.2004.02.030","journal-title":"Am J Med"},{"issue":"1","key":"5880_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","volume":"98","author":"AS Fauci","year":"1983","unstructured":"Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener\u2019s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98(1):76\u201385. https:\/\/doi.org\/10.7326\/0003-4819-98-1-76","journal-title":"Ann Intern Med"},{"key":"5880_CR16","doi-asserted-by":"publisher","unstructured":"Rahmattulla C, de Lind van Wijngaarden RA, Berden AE, Hauer HA, Flo\u00dfmann O, Jayne DR, Gaskin G, Rasmussen N, No\u00ebl LH, Ferrario F, Waldherr R, Wolterbeek R, G\u00f6\u00e7ero\u011flu A, Pusey CD, Hagen EC, Bruijn JA, Bajema IM; European Vasculitis Study Group (EUVAS) (2015) Renal function and ear, nose, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials. Rheumatol (Oxford). 54(5):899\u2013907. https:\/\/doi.org\/10.1093\/rheumatology\/keu357","DOI":"10.1093\/rheumatology\/keu357"},{"issue":"9","key":"5880_CR17","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1080\/08860220802353892","volume":"30","author":"D Frausova","year":"2008","unstructured":"Frausova D, Brejnikova M, Hruskova Z, Rihova Z, Tesar V (2008) Outcome of thirty patients with ANCA-associated renal vasculitis admitted to the intensive care unit. Ren Fail 30(9):890\u2013895. https:\/\/doi.org\/10.1080\/08860220802353892","journal-title":"Ren Fail"},{"issue":"7","key":"5880_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.autrev.2010.02.006","volume":"9","author":"AM Schilder","year":"2010","unstructured":"Schilder AM (2010) Wegener\u2019s Granulomatosis vasculitis and granuloma. Autoimmun Rev 9(7):483\u2013487. https:\/\/doi.org\/10.1016\/j.autrev.2010.02.006","journal-title":"Autoimmun Rev"},{"issue":"12","key":"5880_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.autrev.2010.07.009","volume":"9","author":"PM Villiger","year":"2010","unstructured":"Villiger PM, Guillevin L (2010) Microscopic polyangiitis: Clinical presentation. Autoimmun Rev 9(12):812\u2013819. https:\/\/doi.org\/10.1016\/j.autrev.2010.07.009","journal-title":"Autoimmun Rev"},{"key":"5880_CR20","doi-asserted-by":"publisher","unstructured":"Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA; European Vasculitis Study Group (EUVAS) (2008) Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis. 67(7):1004\u201310. https:\/\/doi.org\/10.1136\/ard.2007.071936","DOI":"10.1136\/ard.2007.071936"},{"key":"5880_CR21","doi-asserted-by":"publisher","unstructured":"Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, H\u00f6glund P, Jayne D, Luqmani R, Mahr A, Mukhtyar C, Pusey C, Rasmussen N, Stegeman C, Walsh M, Westman K; European Vasculitis Study Group (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 70(3):488\u201394. https:\/\/doi.org\/10.1136\/ard.2010.137778","DOI":"10.1136\/ard.2010.137778"},{"issue":"9","key":"5880_CR22","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s11255-016-1330-z","volume":"48","author":"M Rathi","year":"2016","unstructured":"Rathi M, Pinto B, Dhooria A, Sagar V, Mittal T, Rajan R, Dhir V, Kumar S, Sharma K, Nada R, Singh S, Minz RW, Sharma A (2016) Impact of renal involvement on survival in ANCA-associated vasculitis. Int Urol Nephrol 48(9):1477\u20131482. https:\/\/doi.org\/10.1007\/s11255-016-1330-z","journal-title":"Int Urol Nephrol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05880-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05880-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05880-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T16:19:40Z","timestamp":1641313180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05880-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,28]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5880"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05880-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,28]]},"assertion":[{"value":"8 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}